Synopsys Unbilled balances decreased by 5.3% to $43.12M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 58.0%, from $102.58M to $43.12M. Over 5 years (FY 2020 to FY 2025), Unbilled balances shows a downward trend with a -2.2% CAGR.
other_unbilled_contracts_receivable| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $45.86M | $35.59M | $36.32M | $38.02M | $41.86M | $46.25M | $45.81M | $44.27M | $49.26M | $60.02M | $40.52M | $34.81M | $33.60M | $44.17M | $102.58M | $46.16M | $44.94M | $45.53M | $43.12M |
| QoQ Change | — | -22.4% | +2.1% | +4.7% | +10.1% | +10.5% | -1.0% | -3.4% | +11.3% | +21.8% | -32.5% | -14.1% | -3.5% | +31.4% | +132.2% | -55.0% | -2.7% | +1.3% | -5.3% |
| YoY Change | — | — | — | — | -8.7% | +30.0% | +26.1% | +16.4% | +17.7% | +29.8% | -11.6% | -21.4% | -31.8% | -26.4% | +153.1% | +32.6% | +33.7% | +3.1% | -58.0% |